ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: To address this issue, we analyzed 100 newly diagnosed CP-CML patients for BCR-ABL PEMs in CD34+ CML cells using allele-specific oligonucleotide polymerase chain reaction (ASO-PCR) and sequencing, and studied the outcome of these patients after imatinib treatment.